clinicaltrialsarena2d
Exact Sciences post positive results from MRD trial
The US company said that results from the Alpha-CORRECT trial saw its colon cancer diagnostic Oncodetect achieving a ...
Natera to Present New Data at the 2025 ASCO GI Symposium
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that the first set of abstracts have been released from several studies that will be shared at the ...
Le Lézard2d
New Evidence Validates Oncodetect'stm Ability to Detect Molecular Residual Disease and Predict Recurrence in Colorectal Cancer Patients
Exact Sciences Corp. , a leading provider of cancer screening and diagnostic tests, shared clinical validation data for its OncodetectTM MRD test at the 2025 American Society of Clinical Oncology ...